CSC
GH icon

Caldwell Sutter Capital’s Guardant Health GH Stock Holding History

Caldwell Sutter Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11
Closed -$298 – 945
2023
Q4 		$298 Buy
+11
New +$289 ﹤0.01% 905

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Caldwell Sutter Capital's GH Position: Q1 2024 in Review

Caldwell Sutter Capital sold out of Guardant Health (GH) in Q1 2024, closing a stake of 11 shares — an estimated $298 sold.

Caldwell Sutter Capital first reported a position in GH in Q4 2023 and held it in 1 quarter. The position peaked at $298 in Q4 2023. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Caldwell Sutter Capital reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Caldwell Sutter Capital sold 11 Guardant Health shares in Q1 2024, an estimated $298.
  • Caldwell Sutter Capital first reported a position in Guardant Health in Q4 2023 and held it in 1 quarter.
  • Caldwell Sutter Capital's Guardant Health position peaked at $298 in Q4 2023.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Caldwell Sutter Capital's 13F filing for Q1 2024, filed 19 Apr 2024.